Report
Oliver Metzger

SARTORIUS AG : Q3 weaker than estimated on Bioprocess Solutions

>Book-to-bill in BPS 0.88x in Q3 - Q3 came in 3% lower than our forecast, in line with the consensus (FactSet), on sales and 4% lower on adj. EBITDA (margin of 33.6%). Sales growth was only 8.7% y-o-y in Q3 excl. FX (+16.6% y-o-y in 9M 2022). The key weakness was Bioprocess Solutions (BPS), which only showed 7.1% y-o-y excl. FX sales growth due to a strong decline in coronavirus-related revenues (rest of the portfolio with double-digit growth y-o-y). The order intake...
Underlying
Sartorius AG Pref

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Oliver Metzger

Other Reports on these Companies
Other Reports from Oddo BHF
Nicolas David ... (+2)
  • Nicolas David
  • Sinan Doganli
Chaima Ferrandon ... (+2)
  • Chaima Ferrandon
  • Sven Edelfelt

ResearchPool Subscriptions

Get the most out of your insights

Get in touch